+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Fatigue Drug"

Fatigue - Pipeline Insight, 2024 - Product Thumbnail Image

Fatigue - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
Fatigue - Global Clinical Trials Review, H2, 2021 - Product Thumbnail Image

Fatigue - Global Clinical Trials Review, H2, 2021

  • Clinical Trials
  • July 2021
  • 396 Pages
  • Global
From
Fatigue Disease - Global Clinical Trials Review, H1, 2021 - Product Thumbnail Image

Fatigue Disease - Global Clinical Trials Review, H1, 2021

  • Clinical Trials
  • January 2021
  • 392 Pages
  • Global
From
Fatigue - Pipeline Review, H2 2020 - Product Thumbnail Image

Fatigue - Pipeline Review, H2 2020

  • Drug Pipelines
  • July 2020
  • 37 Pages
  • Global
From
  • 4 Results (Page 1 of 1)
Loading Indicator

The Fatigue Drug market is a subset of the Central Nervous System Drugs market, which includes drugs used to treat neurological disorders. Fatigue Drugs are used to treat chronic fatigue syndrome, a condition characterized by extreme fatigue that is not relieved by rest. These drugs are designed to improve energy levels, reduce fatigue, and improve cognitive functioning. Commonly prescribed Fatigue Drugs include stimulants, such as methylphenidate and modafinil, as well as non-stimulants, such as atomoxetine and bupropion. Some companies in the Fatigue Drug market include GlaxoSmithKline, Pfizer, Novartis, and Shire. Other companies, such as Mylan, Sun Pharmaceuticals, and Teva Pharmaceuticals, also produce Fatigue Drugs. Show Less Read more